However, CCL2 expression is significantly higher in bone marrow CD34+ cells of MDS patients compared to healthy controls [42], and CCL2 levels are elevated in the bone marrow plasma of MDS patients as well [80]. Here, CCL2 is linked to myelodysplastic syndrome.